Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. F.G.A. (Frank) Jansman

prof. dr. F.G.A. (Frank) Jansman

Bijzonder hoogleraar Klinische Farmacie, in het bijzonder in de oncologie

Publicaties

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives

Design characteristics of mass balance studies conducted for protein kinase inhibitors

Simplifying fractional polynomials in Bayesian network meta-analysis via variable powers

Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence

Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation

AI schiet te hulp als het menselijk oog tekortschiet: Verbetering toedienveiligheid medicatie met artificial intelligence; stand van zaken

A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions

A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone

Differences in evidentiary requirements for oncology drug effectiveness assessments among six European health technology assessment bodies: can alignment be improved?

Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance

Pers/media

Strijd om de bijsluiter: wie bepaalt de beste dosis voor de patiënt?

BNR Nieuwsradio

Aandacht voor geneesmiddeleninteracties nog niet optimaal.

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 7 – Betaalbare en schone energie

Meer informatie over de Sustainable Development Goals.